Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 22.48 CNY 1.4% Market Closed
Market Cap: 12.7B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Henan Lingrui Pharmaceutical Co Ltd

Revenue
3.6B CNY
Cost of Revenue
-985.6m CNY
Gross Profit
2.6B CNY
Operating Expenses
-1.9B CNY
Operating Income
720.7m CNY
Other Expenses
-44.9m CNY
Net Income
675.8m CNY

Income Statement
Henan Lingrui Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
802
N/A
826
+3%
901
+9%
936
+4%
1 006
+7%
1 085
+8%
1 147
+6%
1 225
+7%
1 315
+7%
1 439
+9%
1 514
+5%
1 609
+6%
1 697
+6%
1 849
+9%
1 990
+8%
2 120
+7%
2 139
+1%
2 053
-4%
2 078
+1%
2 118
+2%
2 149
+1%
2 157
+0%
2 068
-4%
2 163
+5%
2 215
+2%
2 332
+5%
2 430
+4%
2 513
+3%
2 635
+5%
2 694
+2%
2 786
+3%
2 841
+2%
2 917
+3%
3 002
+3%
3 108
+4%
3 200
+3%
3 232
+1%
3 311
+2%
3 432
+4%
3 517
+2%
3 564
+1%
Gross Profit
Cost of Revenue
(331)
(335)
(367)
(379)
(396)
(405)
(423)
(434)
(453)
(471)
(499)
(524)
(531)
(498)
(546)
(556)
(538)
(493)
(516)
(520)
(526)
(494)
(501)
(514)
(522)
(538)
(593)
(647)
(697)
(702)
(769)
(806)
(838)
(832)
(890)
(885)
(903)
(885)
(970)
(969)
(986)
Gross Profit
471
N/A
492
+4%
534
+9%
557
+4%
610
+10%
679
+11%
725
+7%
791
+9%
862
+9%
969
+12%
1 014
+5%
1 084
+7%
1 166
+8%
1 351
+16%
1 444
+7%
1 563
+8%
1 600
+2%
1 560
-3%
1 561
+0%
1 598
+2%
1 623
+2%
1 663
+2%
1 567
-6%
1 649
+5%
1 694
+3%
1 793
+6%
1 837
+2%
1 865
+2%
1 939
+4%
1 992
+3%
2 017
+1%
2 034
+1%
2 079
+2%
2 170
+4%
2 218
+2%
2 315
+4%
2 328
+1%
2 426
+4%
2 462
+1%
2 548
+3%
2 578
+1%
Operating Income
Operating Expenses
(417)
(430)
(452)
(457)
(490)
(542)
(579)
(628)
(686)
(792)
(838)
(879)
(945)
(1 082)
(1 150)
(1 258)
(1 281)
(1 233)
(1 239)
(1 262)
(1 273)
(1 311)
(1 246)
(1 309)
(1 364)
(1 452)
(1 507)
(1 523)
(1 571)
(1 586)
(1 595)
(1 631)
(1 652)
(1 729)
(1 769)
(1 789)
(1 776)
(1 808)
(1 816)
(1 842)
(1 858)
Selling, General & Administrative
(402)
(401)
(447)
(453)
(489)
(508)
(578)
(626)
(685)
(740)
(817)
(856)
(923)
(1 029)
(1 159)
(1 271)
(1 288)
(1 185)
(1 216)
(1 228)
(1 239)
(1 232)
(1 183)
(1 231)
(1 259)
(1 347)
(1 396)
(1 412)
(1 473)
(1 506)
(1 529)
(1 567)
(1 587)
(1 638)
(1 658)
(1 683)
(1 674)
(1 712)
(1 721)
(1 745)
(1 759)
Research & Development
0
(17)
0
0
0
(22)
0
0
0
(43)
0
0
0
(56)
0
0
(11)
(51)
(49)
(65)
(63)
(73)
(78)
(88)
(94)
(90)
(100)
(102)
(110)
(79)
(95)
(89)
(92)
(114)
(126)
(126)
(123)
(97)
(109)
(114)
(118)
Depreciation & Amortization
0
(12)
0
0
0
(13)
0
0
0
(14)
0
0
0
(18)
0
0
0
(31)
0
0
0
(30)
0
0
0
(34)
0
0
0
(30)
0
0
0
(31)
0
0
0
(31)
0
0
0
Other Operating Expenses
(16)
(0)
(5)
(3)
(1)
1
(1)
(2)
(1)
4
(22)
(24)
(23)
21
8
14
18
33
27
32
29
24
16
11
(10)
19
(11)
(8)
13
29
28
25
27
53
15
20
21
32
14
17
19
Operating Income
53
N/A
62
+15%
82
+33%
101
+23%
120
+19%
137
+14%
146
+6%
163
+12%
177
+9%
176
0%
176
+0%
205
+16%
221
+8%
268
+21%
294
+9%
306
+4%
320
+5%
327
+2%
323
-1%
337
+4%
350
+4%
352
+1%
321
-9%
341
+6%
330
-3%
341
+4%
330
-3%
342
+4%
368
+8%
405
+10%
422
+4%
403
-4%
427
+6%
440
+3%
449
+2%
526
+17%
552
+5%
618
+12%
646
+4%
706
+9%
721
+2%
Pre-Tax Income
Interest Income Expense
29
19
23
24
9
12
11
8
247
243
247
244
14
(3)
(11)
(19)
(24)
(29)
(1)
0
2
(10)
(9)
(7)
17
54
60
78
60
30
53
84
88
76
86
43
47
40
61
61
59
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
(15)
0
0
0
1
0
0
0
(4)
(0)
(1)
(1)
(0)
0
(0)
(0)
(28)
0
0
0
0
0
(0)
(0)
1
0
0
0
(2)
0
0
0
Gain/Loss on Disposition of Assets
(1)
(0)
(0)
(1)
(1)
(1)
(1)
0
0
0
1
0
0
(2)
0
0
0
(12)
0
0
0
0
0
0
0
(3)
0
0
0
(20)
0
0
0
(0)
0
0
0
(1)
0
0
0
Total Other Income
2
6
6
7
8
6
9
9
8
5
7
4
4
(1)
(7)
(6)
(7)
1
(11)
(11)
(11)
0
(0)
0
0
0
(3)
(2)
(2)
(1)
(22)
(22)
(22)
0
(1)
(1)
(1)
(3)
(3)
0
0
Pre-Tax Income
84
N/A
86
+3%
111
+29%
131
+19%
136
+4%
154
+13%
164
+6%
180
+9%
432
+140%
409
-5%
431
+5%
453
+5%
239
-47%
264
+10%
273
+4%
279
+2%
287
+3%
283
-1%
311
+10%
325
+5%
340
+5%
341
+0%
312
-9%
334
+7%
347
+4%
364
+5%
387
+6%
418
+8%
426
+2%
413
-3%
453
+10%
464
+2%
494
+6%
517
+5%
534
+3%
568
+6%
598
+5%
653
+9%
704
+8%
768
+9%
780
+2%
Net Income
Tax Provision
(9)
(10)
(14)
(17)
(17)
(21)
(22)
(25)
(64)
(61)
(64)
(68)
(37)
(39)
(42)
(41)
(41)
(38)
(40)
(46)
(49)
(48)
(43)
(47)
(46)
(40)
(42)
(50)
(42)
(51)
(57)
(52)
(53)
(52)
(55)
(56)
(72)
(85)
(90)
(103)
(104)
Income from Continuing Operations
75
76
97
115
119
133
142
155
368
348
367
384
202
225
231
238
246
246
270
279
291
293
269
287
301
324
345
368
384
362
397
413
440
465
479
512
526
568
614
664
676
Income to Minority Interest
(0)
0
0
0
(0)
(1)
(2)
(2)
(3)
(2)
(2)
(3)
(3)
(8)
(9)
(8)
(7)
(3)
(0)
1
1
1
1
1
1
1
1
(0)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
0
0
(0)
(0)
(0)
(0)
Net Income (Common)
75
N/A
76
+2%
97
+27%
115
+19%
119
+3%
132
+11%
141
+7%
152
+8%
365
+140%
346
-5%
365
+5%
381
+5%
198
-48%
217
+9%
223
+3%
230
+3%
239
+4%
243
+2%
270
+11%
280
+4%
292
+4%
294
+1%
270
-8%
288
+7%
302
+5%
326
+8%
346
+6%
368
+6%
383
+4%
362
-6%
396
+9%
412
+4%
440
+7%
465
+6%
479
+3%
512
+7%
526
+3%
568
+8%
614
+8%
664
+8%
676
+2%
EPS (Diluted)
0.14
N/A
0.14
N/A
0.19
+36%
0.22
+16%
0.23
+5%
0.25
+9%
0.26
+4%
0.23
-12%
0.61
+165%
0.58
-5%
0.6
+3%
0.64
+7%
0.34
-47%
0.37
+9%
0.39
+5%
0.4
+3%
0.41
+2%
0.41
N/A
0.45
+10%
0.47
+4%
0.49
+4%
0.51
+4%
0.47
-8%
0.51
+9%
0.54
+6%
0.57
+6%
0.61
+7%
0.65
+7%
0.68
+5%
0.64
-6%
0.7
+9%
0.73
+4%
0.78
+7%
0.84
+8%
0.86
+2%
0.92
+7%
0.94
+2%
1
+6%
1.09
+9%
1.17
+7%
1.22
+4%

See Also

Discover More